Curanex Pharmaceuticals Inc Common Stock Market Cap ($7.99 Million)
Market Cap & Net Worth: Curanex Pharmaceuticals Inc Common Stock (CURX)
Curanex Pharmaceuticals Inc Common Stock market cap. Curanex Pharmaceuticals Inc Common Stock (NASDAQ:CURX) has a market capitalization of $7.99 Million ($7.99 Million) as of November 5, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #27488 globally and #5697 in its home market, demonstrating a 34.56% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Curanex Pharmaceuticals Inc Common Stock's stock price $6.19 by its total outstanding shares 28340812 (28.34 Million). Also see CURX cash flow metrics for how efficiently the company converts equity into cash flow.
Curanex Pharmaceuticals Inc Common Stock Market Cap History (2025–2026)
Curanex Pharmaceuticals Inc Common Stock market cap history from 2025 to 2026. Data shows growth from $9.37 Million to $175.43 Million (0.00% CAGR). Check CURX share price today for real-time trading data and today's change.
Curanex Pharmaceuticals Inc Common Stock Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Curanex Pharmaceuticals Inc Common Stock's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore Curanex Pharmaceuticals Inc Common Stock net asset momentum to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of CURX by Market Capitalization
Companies near Curanex Pharmaceuticals Inc Common Stock in the global market cap rankings as of November 5, 2026. Also see CURX asset base for a full breakdown of the balance sheet.
Key companies related to Curanex Pharmaceuticals Inc Common Stock by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #180 globally with a market cap of $130.90 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #368 globally with a market cap of $76.14 Billion USD.
- CSL Ltd (AU:CSL): Ranked #414 globally with a market cap of $68.22 Billion USD ( AU$96.41 Billion AUD).
- Moderna Inc (NASDAQ:MRNA): Ranked #494 globally with a market cap of $54.14 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #180 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $130.90 Billion | $530.76 |
| #368 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $76.14 Billion | $973.36 |
| #414 | CSL Ltd | AU:CSL | $68.22 Billion | AU$198.72 |
| #494 | Moderna Inc | NASDAQ:MRNA | $54.14 Billion | $228.44 |
Market Capitalization of Curanex Pharmaceuticals Inc Common Stock (2025–2026)
Market capitalization of Curanex Pharmaceuticals Inc Common Stock from 2025 to today. Between 2025 and today, Curanex Pharmaceuticals Inc Common Stock's market cap moved from $9.37 Million to $ 175.43 Million, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $175.43 Million | +1772.35% |
| 2025 | $9.37 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 4th, 2026 the market cap of Curanex Pharmaceuticals Inc Common Stock was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $7.99 Million USD |
| MoneyControl | $7.99 Million USD |
| MarketWatch | $7.99 Million USD |
| marketcap.company | $7.99 Million USD |
| Reuters | $7.99 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Curanex Pharmaceuticals Inc Common Stock
Curanex Pharmaceuticals Inc, a developmental stage pharmaceutical company, discovers, develops, and commercializes botanical drugs to treat patients suffering from inflammatory diseases. It develops Phyto-N for various therapeutic areas, including ulcerative colitis, atopic dermatitis, COVID-19, diabetes, nonalcoholic fatty liver disease, and gout. The company was formerly known as Fordman Pharma… Read more